Vera Therapeutics, Inc. ( VERA) reported that in the pivotal ORIGIN 3 trial of TRUTAKNA (atacicept-vymj), an FDA-approved dual BAFF and APRIL inhibitor, it stabilised kidney function and prevented ...
The U.S. Navy is navigating one of the most consequential transformations in its 245-year history. Adversaries are fielding sophisticated anti-access/area-denial (A2/AD) systems, missile arsenals grow ...
This is my thirteenth Ligand article, following my most recent 06/2026's "Ligand Pharma: Expect Bright And Exciting Future ...
New tariffs shake the cruiser market, Moto Guzzi opens its renovated plant, Sunderland chases a world record, and the TT drops Supertwins.